Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Kura Oncology, Inc. (KURA)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K8-K10-K8-K10-K10-K10-K10-K
Total revenues   [+]0.096.80.085.50.00.00.00.0
            Revenue growth   13.2%      
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.096.80.085.50.00.00.00.0
            Gross margin   100.0% 100.0%    
Selling, general and administrative   [+]139.947.1131.346.591.967.516.19.7
Research and development        46.826.4
Other operating expenses  8.5 2.4 5.79.82.7-0.1
EBITDA   [+]      -65.6-35.9
            EBITDA margin   51.4% 45.6%    
Depreciation and amortization        0.00.0
EBIT   [+]-148.449.8-133.739.0-97.6-77.3-65.6-35.9
            EBIT margin   51.4% 45.6%    
Interest income, net   [+]4.3 1.2 2.94.9-1.0-0.9
Other income (expense), net   [+]8.5-185.62.4-169.45.79.86.11.4
Pre-tax income  -135.8-135.8-130.5-130.5-89.6-63.1-60.4-35.4
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -135.8-135.8-130.5-130.5-89.6-63.1-60.4-35.4
            Net margin   -140.3% -152.6%    
   
Basic EPS   [+]($2.03)($2.03)($1.97)($1.97)($1.69)($1.51)($1.72)($1.52)
Diluted EPS   [+]($2.03)($2.03)($1.97)($1.97)($1.69)($1.51)($1.72)($1.52)
   
Shares outstanding (basic)   [+]67.067.066.466.453.141.935.223.2
Shares outstanding (diluted)   [+]67.067.066.466.453.141.935.223.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy